[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$2211b Graphic $2211b

UnitedHealth Group ($UNH) is being discussed as potentially undervalued despite recent price drops. Social engagement is up, but there are concerns about near-term weakness.

About $2211b

Social media discussion around the ticker $2211b, likely related to financial markets.

Insights #

Engagements: X #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: XX
1-Year High: XXX on 2025-06-26
1-Year Low: X on 2025-05-19

Social Network X
Engagements X

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +100%
1 Month: X +300%
1-Year High: X on 2025-05-07
1-Year Low: X on 2025-05-06

Social Network X
Mentions X

Creators: X #


Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $2211b in the last XX hours which is no change from in the previous XX hours Daily Average: X
1 Week: X +100%
1 Month: X +300%
1-Year High: X on 2025-05-07
1-Year Low: X on 2025-05-06

Top assets mentioned In the posts about $2211b in the last XX hours

UnitedHealth Group (UNH)

Top topics mentioned In the posts about $2211b in the last XX hours

$410b, rsi, $unh, stocks healthcare, $8800b, $2235b, $2050b, $2040b, subscription, eps, $276b, investment

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"💲💲💲 BUY BUY BUY 💲💲💲 United Health ( $UNH) is currently trading at $XXXXXX but I see its fair market value is under pressure. With a trailing P/E of XXXXX and forward P/E of XXXX UNH looks undervalued relative to its strong revenue of $410B and net income of $22.11B trailing twelve months. However profit margin is only XXX% and recent price action shows a XXX% drop today with RSI at XXXXX indicating some near-term weakness. Given its solid fundamentals but recent conservative outlook and lowered price targets from Morgan Stanley I estimate fair value in the $300$320 range over the next"
@jbtcapital on X 2025-07-18 12:21:53 UTC XXX followers, XX engagements